1-18 of 18
Authors: Joachim P Steinbach
Save search
Sort by
Journal Article

CNSC-16. ASSOCIATION BETWEEN RESTING-STATE-NETWORK FUNCTIONAL CONNECTIVITY AND SURVIVAL IN RECURRENT GLIOMAS DIAGNOSED USING FET PET

PDF
Michel Friedrich and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Pages viii43–viii44, https://doi.org/10.1093/neuonc/noae165.0172
Published: 11 November 2024
Journal Article

Disturbance in cerebral blood microcirculation and hypoxic-ischemic microenvironment are associated with the development of brain metastasis

PDF
Jenny Roesler and others
Neuro-Oncology, Volume 26, Issue 11, November 2024, Pages 2084–2099, https://doi.org/10.1093/neuonc/noae094
Published: 04 June 2024
Includes: Multimedia
Journal Article

Intracranial injection of natural killer cells engineered with a HER2-targeted chimeric antigen receptor in patients with recurrent glioblastoma

PDF
Michael C Burger and others
Neuro-Oncology, Volume 25, Issue 11, November 2023, Pages 2058–2071, https://doi.org/10.1093/neuonc/noad087
Published: 06 May 2023
Journal Article
EDITOR'S CHOICE

Superiority of temozolomide over radiotherapy for elderly patients with RTK II methylation class, MGMT promoter methylated malignant astrocytoma

PDF
Antje Wick and others
Neuro-Oncology, Volume 22, Issue 8, August 2020, Pages 1162–1172, https://doi.org/10.1093/neuonc/noaa033
Published: 17 February 2020
Journal Article

Quality of life in the GLARIUS trial randomizing bevacizumab/irinotecan versus temozolomide in newly diagnosed, MGMT-nonmethylated glioblastoma

PDF
Niklas Schäfer and others
Neuro-Oncology, Volume 20, Issue 7, July 2018, Pages 975–985, https://doi.org/10.1093/neuonc/nox204
Published: 07 November 2017
Journal Article

To diet or not to diet – that is still the question

PDF
Johannes Rieger and Joachim P. Steinbach
Neuro-Oncology, Volume 18, Issue 8, August 2016, Pages 1035–1036, https://doi.org/10.1093/neuonc/now131
Published: 05 July 2016
Journal Article

A Phase II randomized study of galunisertib monotherapy or galunisertib plus lomustine compared with lomustine monotherapy in patients with recurrent glioblastoma

PDF
Alba A. Brandes and others
Neuro-Oncology, Volume 18, Issue 8, August 2016, Pages 1146–1156, https://doi.org/10.1093/neuonc/now009
Published: 21 February 2016
Journal Article

Differential expression of vascular endothelial growth factor A, its receptors VEGFR-1, -2, and -3 and co-receptors neuropilin-1 and -2 does not predict bevacizumab response in human astrocytomas

PDF
Peter Baumgarten and others
Neuro-Oncology, Volume 18, Issue 2, February 2016, Pages 173–183, https://doi.org/10.1093/neuonc/nov288
Published: 30 November 2015
Journal Article

NIMG-40MRI TUMOR PROGRESSION PATTERNS IN THE GLARIUS TRIAL

PDF
Sied Kebir and others
Neuro-Oncology, Volume 17, Issue suppl_5, November 2015, Pages v162–v163, https://doi.org/10.1093/neuonc/nov225.40
Published: 09 November 2015
Journal Article

NIMG-41MRI FINDINGS IN THE GLARIUS TRIAL: PROGNOSTIC AND PREDICTIVE IMPLICATIONS

PDF
Sied Kebir and others
Neuro-Oncology, Volume 17, Issue suppl_5, November 2015, Page v163, https://doi.org/10.1093/neuonc/nov225.41
Published: 09 November 2015
Journal Article
EDITOR'S CHOICE

Human cytomegalovirus infection in tumor cells of the nervous system is not detectable with standardized pathologico-virological diagnostics Get access

PDF
Peter Baumgarten and others
Neuro-Oncology, Volume 16, Issue 11, November 2014, Pages 1469–1477, https://doi.org/10.1093/neuonc/nou167
Published: 25 August 2014
Journal Article

ERBB2/HER2-SPECIFIC NATURAL KILLER CELLS FOR ADOPTIVE IMMUNOTHERAPY OF GLIOBLASTOMA Get access

PDF
Joachim P. Steinbach and others
Neuro-Oncology, Volume 16, Issue suppl_3, July 2014, Page iii44, https://doi.org/10.1093/neuonc/nou209.9
Published: 01 July 2014
Journal Article

MOLECULAR GENETIC DETERMINANTS OF LONG-TERM SURVIVAL WITH GLIOBLASTOMA Get access

PDF
Michael Weller and others
Neuro-Oncology, Volume 16, Issue suppl_3, July 2014, Pages iii46–iii47, https://doi.org/10.1093/neuonc/nou209.19
Published: 01 July 2014
Journal Article

Quantitative T2 mapping of recurrent glioblastoma under bevacizumab improves monitoring for non-enhancing tumor progression and predicts overall survival Get access

PDF
Elke Hattingen and others
Neuro-Oncology, Volume 15, Issue 10, October 2013, Pages 1395–1404, https://doi.org/10.1093/neuonc/not105
Published: 07 August 2013
Journal Article

Enzastaurin before and concomitant with radiation therapy, followed by enzastaurin maintenance therapy, in patients with newly diagnosed glioblastoma without MGMT promoter hypermethylation Get access

PDF
Wolfgang Wick and others
Neuro-Oncology, Volume 15, Issue 10, October 2013, Pages 1405–1412, https://doi.org/10.1093/neuonc/not100
Published: 01 August 2013
Journal Article

Malignant astrocytomas of elderly patients lack favorable molecular markers: an analysis of the NOA-08 study collective Get access

PDF
Benedikt Wiestler and others
Neuro-Oncology, Volume 15, Issue 8, August 2013, Pages 1017–1026, https://doi.org/10.1093/neuonc/not043
Published: 17 April 2013
Journal Article

Bevacizumab impairs oxidative energy metabolism and shows antitumoral effects in recurrent glioblastomas: a 31P/1H MRSI and quantitative magnetic resonance imaging study Get access

PDF
Elke Hattingen and others
Neuro-Oncology, Volume 13, Issue 12, December 2011, Pages 1349–1363, https://doi.org/10.1093/neuonc/nor132
Published: 02 September 2011
Journal Article

Bevacizumab-induced tumor calcifications as a surrogate marker of outcome in patients with glioblastoma Get access

PDF
Oliver Bähr and others
Neuro-Oncology, Volume 13, Issue 9, September 2011, Pages 1020–1029, https://doi.org/10.1093/neuonc/nor099
Published: 31 July 2011